|Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial|
LM Laffel, LG Kanapka, RW Beck, K Bergamo, MA Clements, A Criego, ...
Jama 323 (23), 2388-2396, 2020
|Closed-loop control during intense prolonged outdoor exercise in adolescents with type 1 diabetes: the artificial pancreas ski study|
MD Breton, DR Cher˝avvsky, GP Forlenza, MD DeBoer, J Robic, ...
Diabetes care 40 (12), 1644-1650, 2017
|Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes|
E Cobry, K McFann, L Messer, V Gage, B VanderWel, L Horton, ...
Diabetes technology & therapeutics 12 (3), 173-177, 2010
|Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes|
CE Taplin, E Cobry, L Messer, K McFann, HP Chase, R Fiallo-Scharer
The Journal of pediatrics 157 (5), 784-788. e1, 2010
|Optimizing hybrid closed-loop therapy in adolescents and emerging adults using the MiniMed 670G system|
LH Messer, GP Forlenza, JL Sherr, RP Wadwa, BA Buckingham, ...
Diabetes Care 41 (4), 789-796, 2018
|Effect of acetaminophen on CGM glucose in an outpatient setting|
DM Maahs, D DeSalvo, L Pyle, T Ly, L Messer, P Clinton, E Westfall, ...
Diabetes Care 38 (10), e158-e159, 2015
|Real world hybrid closed‐loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months|
LH Messer, C Berget, T Vigers, L Pyle, C Geno, RP Wadwa, KA Driscoll, ...
Pediatric diabetes 21 (2), 319-327, 2020
|A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk|
MJ Redondo, S Geyer, AK Steck, S Sharp, JM Wentworth, MN Weedon, ...
Diabetes care 41 (9), 1887-1894, 2018
|Closed-loop control without meal announcement in type 1 diabetes|
FM Cameron, TT Ly, BA Buckingham, DM Maahs, GP Forlenza, CJ Levy, ...
Diabetes technology & therapeutics 19 (9), 527-532, 2017
|Six months of hybrid closed loop in the real‐world: an evaluation of children and young adults using the 670G system|
C Berget, LH Messer, T Vigers, BI Frohnert, L Pyle, RP Wadwa, ...
Pediatric diabetes 21 (2), 310-318, 2020
|Preserving skin integrity with chronic device use in diabetes|
LH Messer, C Berget, C Beatson, S Polsky, GP Forlenza
Diabetes technology & therapeutics 20 (S2), S2-54-S2-64, 2018
|Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes|
SA Brown, GP Forlenza, BW Bode, JE Pinsker, CJ Levy, AB Criego, ...
Diabetes Care 44 (7), 1630-1640, 2021
|Best friend or spy: a qualitative meta‐synthesis on the impact of continuous glucose monitoring on life with type 1 diabetes|
LH Messer, R Johnson, KA Driscoll, J Jones
Diabetic Medicine 35 (4), 409-418, 2018
|Genetic mapping of a mouse modifier gene that can prevent ALS onset|
CB Kunst, L Messer, J Gordon, J Haines, D Patterson
Genomics 70 (2), 181-189, 2000
|Successful at-home use of the tandem control-IQ artificial pancreas system in young children during a randomized controlled trial|
GP Forlenza, L Ekhlaspour, M Breton, DM Maahs, RP Wadwa, M DeBoer, ...
Diabetes technology & therapeutics 21 (4), 159-169, 2019
|The increasing onset of type 1 diabetes in children|
K Hummel, KK McFann, J Realsen, LH Messer, GJ Klingensmith, ...
The Journal of pediatrics 161 (4), 652-657. e1, 2012
|Fully closed-loop multiple model probabilistic predictive controller artificial pancreas performance in adolescents and adults in a supervised hotel setting|
GP Forlenza, FM Cameron, TT Ly, D Lam, DP Howsmon, N Baysal, ...
Diabetes technology & therapeutics 20 (5), 335-343, 2018
|Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes|
DM Wilson, PM Calhoun, DM Maahs, HP Chase, L Messer, ...
Diabetes technology & therapeutics 17 (6), 385-391, 2015
|Automated hybrid closed‐loop control with a proportional‐integral‐derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimalá…|
TT Ly, SA Weinzimer, DM Maahs, JL Sherr, A Roy, B Grosman, ...
Pediatric diabetes 18 (5), 348-355, 2017
|Cost, hassle, and on-body experience: barriers to diabetes device use in adolescents and potential intervention targets|
LH Messer, ML Tanenbaum, PF Cook, JJ Wong, SJ Hanes, KA Driscoll, ...
Diabetes technology & therapeutics 22 (10), 760-767, 2020